TCR2 THERAPEUTICS INC - COM (TCRR)

CUSIP: 87808K106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
37,274,984
Share change
+5,345,565
Total reported value
$823,022,807
Put/Call ratio
141%
Price per share
$22.08
Number of holders
124
Value change
+$107,488,715
Number of buys
77
Number of sells
41

Quarterly Holders Quick Answers

What is CUSIP 87808K106?
CUSIP 87808K106 identifies TCRR - TCR2 THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q1 2021

As of 31 Mar 2021, TCR2 THERAPEUTICS INC - COM (TCRR) was held by 124 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,274,984 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, MPM ASSET MANAGEMENT LLC, Redmile Group, LLC, MPM Oncology Impact Management LP, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, VICTORY CAPITAL MANAGEMENT INC, ArrowMark Colorado Holdings LLC, and Cormorant Asset Management, LP. This page lists 124 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.